For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, 89bio Inc’s stock clocked out at $9.31, up 2.53% from its previous closing price of $9.08. In other words, the price has increased by $2.53 from its previous closing price. On the day, 0.58 million shares were traded. ETNB stock price reached its highest trading level at $9.78 during the session, while it also had its lowest trading level at $9.12.
Ratios:
To gain a deeper understanding of ETNB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.04 and its Current Ratio is at 20.04. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On January 12, 2024, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $24 to $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’24 when PALEKAR ROHAN sold 52,718 shares for $10.91 per share. The transaction valued at 575,153 led to the insider holds 459,171 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 1,350,000 shares of ETNB for $20,722,500 on Mar 04 ’24. The Director now owns 12,431,584 shares after completing the transaction at $15.35 per share. On Feb 26 ’24, another insider, PALEKAR ROHAN, who serves as the Chief Executive Officer of the company, sold 4,477 shares for $10.76 each. As a result, the insider received 48,173 and left with 486,889 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ETNB now has a Market Capitalization of 886542016 and an Enterprise Value of 318734272.
Stock Price History:
The Beta on a monthly basis for ETNB is 1.02, which has changed by -0.397411 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, ETNB has reached a high of $22.93, while it has fallen to a 52-week low of $6.57. The 50-Day Moving Average of the stock is -15.37%, while the 200-Day Moving Average is calculated to be -23.25%.
Shares Statistics:
It appears that ETNB traded 1.29M shares on average per day over the past three months and 788190 shares per day over the past ten days. A total of 93.27M shares are outstanding, with a floating share count of 88.56M. Insiders hold about 7.00% of the company’s shares, while institutions hold 101.87% stake in the company. Shares short for ETNB as of 1711584000 were 11549623 with a Short Ratio of 8.96, compared to 1709164800 on 10862437. Therefore, it implies a Short% of Shares Outstanding of 11549623 and a Short% of Float of 14.130001.
Earnings Estimates
The current assessment of 89bio Inc (ETNB) involves the perspectives of 8 analysts closely monitoring its market dynamics.On average, analysts expect EPS of $-0.46 for the current quarter, with a high estimate of $-0.4 and a low estimate of $-0.57, while EPS last year was $-0.54. The consensus estimate for the next quarter is $-0.51, with high estimates of $-0.38 and low estimates of $-0.68.
Analysts are recommending an EPS of between $-1.55 and $-2.82 for the fiscal current year, implying an average EPS of $-2.07. EPS for the following year is $-2.61, with 10 analysts recommending between $-1.69 and $-3.4.
